Cytek Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTKB and other ETFs, options, and stocks.About CTKB
Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS, Cytek Aurora, Cytek Northern Lights, and Cytek NL-CLC.
CEOWen Bin Jiang
CEOWen Bin Jiang
Employees648
Employees648
HeadquartersFremont, California
HeadquartersFremont, California
Founded1992
Founded1992
Employees648
Employees648
CTKB Key Statistics
Market cap638.69M
Market cap638.69M
Price-Earnings ratio-49.36
Price-Earnings ratio-49.36
Dividend yield—
Dividend yield—
Average volume1.21M
Average volume1.21M
High today$5.21
High today$5.21
Low today$4.92
Low today$4.92
Open price$5.19
Open price$5.19
Volume1.26M
Volume1.26M
52 Week high$7.30
52 Week high$7.30
52 Week low$2.37
52 Week low$2.37
Stock Snapshot
As of today, Cytek Biosciences(CTKB) shares are valued at $5.10. The company's market cap stands at 638.69M, with a P/E ratio of -49.36.
On 2025-12-06, Cytek Biosciences(CTKB) stock traded between a low of $4.92 and a high of $5.21. Shares are currently priced at $5.10, which is +3.7% above the low and -2.1% below the high.
The Cytek Biosciences(CTKB)'s current trading volume is 1.26M, compared to an average daily volume of 1.21M.
In the last year, Cytek Biosciences(CTKB) shares hit a 52-week high of $7.30 and a 52-week low of $2.37.
In the last year, Cytek Biosciences(CTKB) shares hit a 52-week high of $7.30 and a 52-week low of $2.37.
People also own
Based on the portfolios of people who own CTKB. This list is generated using Robinhood data, and it’s not a recommendation.